Do Novel Mechanisms for Depression Treatment Herald Brighter Days Ahead for Patients With Residual Anhedonia?

Gain in-depth knowledge on the pathophysiology and patient burden of major depressive disorder and residual anhedonia symptoms by attending CCO’s 11th Annual Mood Disorders Summit 2024 and downloading an expert-curated slideset.

Share

Program Content

Activities

Anhedonia Mood Disorders 2024 DL
Do Novel Mechanisms for Depression Treatment Herald Brighter Days Ahead for Patients With Residual Anhedonia?
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2024

Expires: September 09, 2025

Faculty

cover img faculity

Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is not commercially supported.

Independent Educational Activity